Astrazeneca to start Phase 1/2 clinical trials of coronavirus vaccine in Japan

Astrazeneca is going to start beginning Phase 1/2 clinical trials coronavirus vaccine in Japan, the company said today.

Trials of the vaccine, known as AZD1222, will be held at multiple facilities in Japan, targeting 250 subjects, the company said in a release.

  Learn about the COVID-19 pandemic from News Hour  

The British company is working with Daiichi Sankyo, JCR Pharma and other partners in Japan to make and distribute the vaccine.

Follow News Hour
News Hour Correspondent

This article has been posted by a News Hour Correspondent. For queries, please contact through [email protected]
No Comments
Scroll Up
%d bloggers like this: